The detected variants in different signaling pathway related genes including ABL1, PIK3CB and PTPN11 in MBC-CML patients may affect ErbB, PI3K-Akt, Ras-MAPK cascade and JAK-STAT signaling pathways15–17. This evidence concerns the gene EGFR and chronic myelogenous leukemia, BCR-ABL1 positive.